Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research

In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines a...

Full description

Bibliographic Details
Main Author: Coelho, André (author)
Other Authors: Alvites, Rui Damásio (author), Branquinho, Mariana Vieira (author), Guerreiro, Susana G. (author), Maurício, Ana Colette (author)
Format: article
Language:eng
Published: 2021
Subjects:
Cell-based therapies
Secretome
Mesenchymal stem cells
Coronavirus
SARS-CoV-2
Online Access:http://hdl.handle.net/10400.22/16649
Country:Portugal
Oai:oai:recipp.ipp.pt:10400.22/16649
Description
Summary:In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines and specific treatments are not yet available. There are several strategies currently being studied for the treatment of adverse symptoms of COVID-19, that encompass Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS), extensive pulmonary inflammation, cytokine storm, and pulmonary edema, due to virus-induced pneumonia.

Similar Items